Humans Janus Kinase Inhibitors Syndrome Arthritis, Juvenile Drug Development Still's Disease, Adult-Onset
This editorial refers to the article ‘JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis’, published by Gillard L. et al., 2023;62: 1594–1604.